. Experimental design. Cultures were established in soil microcosms in a full-factorial design with two levels of culture (single-species, co-culture), two levels of plasmid (plasmid-free, pQBR57), and two levels of mercury (0 µg/g Hg(II), 16 µg/g Hg(II)). Six replicates were established for each combination of treatments, only one is shown. Every four days samples were transferred into fresh media for a total of 65 growth cycles, after which clones were isolated and subjected to genomic and phenotypic analysis. *Note that similar single-species cultures were also established and run for P. putida. Table S1 . Parallel mutations detected in whole-genome resequencing. Parallel mutations (n=35) were identified as loci mutated in clones from >1 population.
To identify mutations associated with the different treatments, parallel chromosomal mutations occurring in >1 population from one treatment and not in the other level of that treatment (n=23) were subjected to sequential Bonferroni-corrected Fisher's Exact Test for association with each treatment (m=23x3 tests).
A significant result before adjustment for multiple testing is indicated by an asterisk, an additional asterisk in the 'p < alpha (adj)' indicates significance after multiple testing. Table S2 . Second-site mutations in sequenced P. fluorescens clones. Filled cells indicate a mutation was detected in that clone, with fill colour corresponding to mutation type: speckled white = 'modifier' (intergenic SNV); light-grey = 'low' impact SNV (synonymous mutation); mid-grey = 'moderate' impact SNV (substitutions, in-frame indels); dark grey = 'high' impact SNV (stop codons, frameshift); black = deletion; hatched purple = Tn5042 insertion; hatched green = Tn4652 insertion; hatched orange = Tn6290 insertion; hatched blue = Tn6291 insertion. For the actP insertions, the nature of the mutation is given by the colour, corresponding to Figure 4 : red = inframe deletion; blue = inframe insertion; green = missense; purple = frameshift. Mobile genetic element insertions in PQBR57_0189 and PQBR57_0190-0191, indicated by a *, did not occur independently (i.e. they were present in ancestral clones) and thus not presented in Figure 2 or Supplementary Table 1 . Table S3 . Data presented in Figure 1 . Table S4 . Data presented in Figure 3 . Table S5 . Data presented in Figure 4 . Table S6 . Data presented in Figure S3 . Table S7 . Data presented in Figure S4 . Table S8 . Data presented in Figure S5A . Table S9 . Data presented in Figure S5B .
Tables S3-S9 are provided as an Excel workbook.
Supplementary Text: Discussion of parallel mutations
We detected 35 loci which were mutated in >1 population (Supplementary Table 1 ). Of these, only actP from Pseudomonas fluorescens SBW25 was significantly associated with an experimental treatment following correction for multiple testing. Three other genes were identified as non-significant following correction for multiple testing: katA and PFLU_4242
(also from P. fluorescens SBW25), and katA and PP_0021 (from P. putida KT2440). These, as well as other parallel mutations of interest, are discussed here. gacA/S global regulator (P. putida). The gacA/S regulator was frequently disrupted in P.
putida (but never in P. fluorescens) across treatments, however unlike for P. fluorescens (cf.
Harrison et al. 2015), P. putida gacA/S disruption is unlikely to be connected with plasmid amelioration since mutations also arose in plasmid-free treatments.
PFLU_0940 putative cell division protein, PFLU_0941 putative peptidoglycan glycosyltransferase, PFLU_5421 peptidoglycan-related, ftsB cell division protein (P. 
